DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Bal Pharma Limited (BALPHARMA) share price today?

Bal Pharma Limited (BALPHARMA) is trading at ₹96 on the NSE, down 1.78% on the day. Source: DocStoX.

What is the PE ratio of Bal Pharma Limited?

Bal Pharma Limited has a price-to-earnings (PE) ratio of 24.3 in the Healthcare sector.

What is the market capitalisation of Bal Pharma Limited?

Bal Pharma Limited has a market capitalisation of approximately ₹153 crore.

Is Bal Pharma Limited a profitable company?

Bal Pharma Limited generates a return on equity of 7.6% with a net profit margin of 2.0%. That is a modest return on shareholder capital.

What is the 52-week high and low of BALPHARMA?

Bal Pharma Limited (BALPHARMA) has traded between ₹60 and ₹124.6 over the past 52 weeks, against a current price of ₹96.

Does Bal Pharma Limited pay a dividend?

Yes. Bal Pharma Limited currently offers a dividend yield of 1.13%. Dividend payments depend on the board's declaration each year.

Bal Pharma Limited

₹96.00▼ -1.74 (-1.78%)

BALPHARMA·NSE·Healthcare

Market Cap

152.60 Cr

PE Ratio

24.30

Volume

5,237

Day High - Low

99.00 - 95.15

52W High-Low

124.60 - 60.00

₹96.00▼ -1.74 (-1.78%)

Market Cap152.60 Cr

PE Ratio24.30

Volume5,237

Day High - Low99.00 - 95.15

52W High-Low124.60 - 60.00

Bal Pharma Limited (BALPHARMA): company summary

Bal Pharma Ltd's annual revenue rose 2.9% to ₹312 crore, but net profit fell 9.7% to ₹6 crore.

Bal Pharma Limited (BALPHARMA) is a micro-cap Healthcare company valued at ₹153 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Bal Pharma Limited last traded at ₹96, modestly down 1.78% on the day.
Recent developments: On 2026-09-17, the company announced a dividend of ₹1.20 per share, ex-date. In the latest quarter, net profit turned positive after being zero in the same quarter a year earlier, reflecting improved profitability.
Financial performance: Bal Pharma Ltd's annual revenue rose 2.9% to ₹312 crore, but net profit fell 9.7% to ₹6 crore. The latest quarter saw revenue jump 34.5% to ₹89 crore and net profit surge 442.9% to ₹1 crore, indicating strong recent performance despite annual profit decline.
Valuation multiples: The stock trades at 24.3 times earnings, a discount to the Healthcare median of 32.0, 2.06 times book value. It yields 1.1%.
Things to watch: The company's net profit margin narrowed 0.3 percentage points to 2.0%, and its debt to equity ratio remains high at 1.94. The stock is 15.1% below its 52-week high, and the latest quarter's net profit was zero a year ago.
Where it stands: Bal Pharma Ltd ended the latest quarter with net profit of ₹1 crore, up 442.9% from the same quarter a year earlier, while annual net profit fell 9.7% to ₹6 crore. The stock is 15.1% below its 52-week high, and the company's debt to equity ratio remains at 1.94.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

4.1/10

Weak

Fair Value

ROE

7.64%

Weak

P/E

24.30x

Fair

Debt / Equity

1.94

High

Industry

Healthcare

Pharmaceuticals

Overall View

Weak

Price performance

Day₹95.15

₹99.00

52W₹60.00

₹124.60

DocStoX take

Held back by growth (3.0).

DocStoX score

Low confidence

4.1

/10

Weak

Quality

Modest

ROE 7.6%

Valuation

Rich

P/E 24.3×

Growth

Slow

Revenue +4.4% 5Y CAGR

Risk

Moderate

D/E 1.94

Momentum

Firm

56% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹96

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹153 Cr

52W High / Low

₹125 / ₹60

Dividend Yield

1.13%

Promoter Holding

50.86%

EPS (TTM)

₹3.95

Book Value

₹51.65

Key highlights

Profitable in all of the last 5 years
High leverage — debt is 1.9× equity
Small ₹153 cr company — thinner liquidity

1 Positive2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Bal Pharma Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Bal Pharma Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Bal Pharma Limited with peers

Bal Pharma Limited vs Sun Pharmaceutical Industries Limited Bal Pharma Limited vs Divi's Laboratories Limited Bal Pharma Limited vs Torrent Pharmaceuticals Limited Bal Pharma Limited vs Apollo Hospitals Enterprise Limited Bal Pharma Limited vs Zydus Lifesciences Limited Bal Pharma Limited vs Laurus Labs Limited

Related tools & concepts

Value Bal Pharma Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

BALPHARMA newsLatest coverage & filings Open screenerFilter the whole market